NO20040922L - Glycin-substituerte tieno [2,3-d]pyrimidiner med kombinert LH- og FSH-agonistisk aktivitet - Google Patents

Glycin-substituerte tieno [2,3-d]pyrimidiner med kombinert LH- og FSH-agonistisk aktivitet

Info

Publication number
NO20040922L
NO20040922L NO20040922A NO20040922A NO20040922L NO 20040922 L NO20040922 L NO 20040922L NO 20040922 A NO20040922 A NO 20040922A NO 20040922 A NO20040922 A NO 20040922A NO 20040922 L NO20040922 L NO 20040922L
Authority
NO
Norway
Prior art keywords
pyrimidines
glycine
combined
agonistic activity
substituted thieno
Prior art date
Application number
NO20040922A
Other languages
English (en)
Other versions
NO328792B1 (no
Inventor
Cornelis Marius Timmers
Robert Gerard Jules Ma Hanssen
Jan Kelder
Original Assignee
Akzo Nobel Coatings Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Coatings Int Bv filed Critical Akzo Nobel Coatings Int Bv
Publication of NO20040922L publication Critical patent/NO20040922L/no
Publication of NO328792B1 publication Critical patent/NO328792B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20040922A 2001-09-04 2004-03-03 Glycin-substituerte tieno [2,3-d]pyrimidiner, farmasoytiske preparater omfattende slike samt anvendelse av slike for fremstilling av medikament for kontroll av fruktbarhet NO328792B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01203328 2001-09-04
PCT/EP2002/009648 WO2003020727A1 (en) 2001-09-04 2002-08-29 GLYCINE-SUBSTITUTED THIENO [2,3-d]PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY

Publications (2)

Publication Number Publication Date
NO20040922L true NO20040922L (no) 2004-03-03
NO328792B1 NO328792B1 (no) 2010-05-18

Family

ID=8180877

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040922A NO328792B1 (no) 2001-09-04 2004-03-03 Glycin-substituerte tieno [2,3-d]pyrimidiner, farmasoytiske preparater omfattende slike samt anvendelse av slike for fremstilling av medikament for kontroll av fruktbarhet

Country Status (27)

Country Link
US (1) US7375109B2 (no)
EP (1) EP1427734B1 (no)
JP (1) JP4263094B2 (no)
KR (1) KR100891630B1 (no)
CN (1) CN1261437C (no)
AR (1) AR036408A1 (no)
AT (1) ATE309251T1 (no)
AU (1) AU2002333750B2 (no)
BR (1) BR0212173A (no)
CA (1) CA2457212C (no)
CY (1) CY1106052T1 (no)
DE (1) DE60207280T2 (no)
DK (1) DK1427734T3 (no)
EC (1) ECSP044990A (no)
ES (1) ES2252540T3 (no)
HR (1) HRP20040194A2 (no)
HU (1) HUP0401443A3 (no)
IL (2) IL160194A0 (no)
IS (1) IS2419B (no)
MX (1) MXPA04002046A (no)
NO (1) NO328792B1 (no)
NZ (1) NZ531375A (no)
PE (1) PE20030467A1 (no)
PL (1) PL368388A1 (no)
RU (1) RU2294331C2 (no)
WO (1) WO2003020727A1 (no)
ZA (1) ZA200401459B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890923B2 (en) * 2002-12-16 2005-05-10 Astrazeneca Ab Compounds
KR100666484B1 (ko) * 2005-02-04 2007-01-09 삼성전자주식회사 반도체 메모리 장치의 입출력 회로 및 입출력 방법
US8741259B2 (en) * 2008-10-20 2014-06-03 Marvin C. Gershengorn Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists
CN101762915B (zh) * 2008-12-24 2013-04-17 北京京东方光电科技有限公司 Tft-lcd阵列基板及其驱动方法
EP2563777A4 (en) 2010-04-08 2013-09-04 Us Health INVERSE AGONISTS AND NEUTRAL AGONISTS FOR THE TSH RECEPTOR
PT3415517T (pt) 2012-09-28 2022-05-13 Takeda Pharmaceuticals Co Forma cristalina de 1-(4-1-(2,6-difluorobenzil)-5- dimetilaminometil-3-(6-metoxipiridazin-3-il)-2,4-dioxo- 1,2,3,4-tetrahidrotieno(2,3-d)-pirimidin-6-il)fenil)-3- metoxiureia
CN115279769A (zh) 2019-10-10 2022-11-01 梦欧文科学有限责任公司 N-(4-(1-(2,6-二氟苄基)-5-((二甲基氨基)甲基)-3-(6-甲氧基-3-哒嗪基)-2,4-二氧代-1,2,3,4-四氢噻吩并[2,3-d]嘧啶-6-基)苯基)-n’-甲氧基脲的结晶形式

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2054784T3 (es) 1987-08-08 1994-08-16 Akzo Nv Un metodo para la fabricacion de un implante.
DE19632423A1 (de) * 1996-08-12 1998-02-19 Merck Patent Gmbh Thienopyrimidine
TW564247B (en) 1999-04-08 2003-12-01 Akzo Nobel Nv Bicyclic heteraromatic compound

Also Published As

Publication number Publication date
ATE309251T1 (de) 2005-11-15
CN1261437C (zh) 2006-06-28
AR036408A1 (es) 2004-09-08
CA2457212C (en) 2011-02-15
PE20030467A1 (es) 2003-05-26
DE60207280T2 (de) 2006-05-18
RU2004110036A (ru) 2005-10-10
EP1427734B1 (en) 2005-11-09
EP1427734A1 (en) 2004-06-16
CY1106052T1 (el) 2011-04-06
NO328792B1 (no) 2010-05-18
IL160194A0 (en) 2004-07-25
IL160194A (en) 2009-06-15
DE60207280D1 (de) 2005-12-15
AU2002333750B2 (en) 2008-02-21
ES2252540T3 (es) 2006-05-16
CA2457212A1 (en) 2003-03-13
US7375109B2 (en) 2008-05-20
JP2005504784A (ja) 2005-02-17
DK1427734T3 (da) 2006-03-06
RU2294331C2 (ru) 2007-02-27
PL368388A1 (en) 2005-03-21
KR20040029135A (ko) 2004-04-03
IS7152A (is) 2004-02-13
ECSP044990A (es) 2004-04-28
HUP0401443A3 (en) 2008-05-28
US20040180907A1 (en) 2004-09-16
MXPA04002046A (es) 2004-07-16
JP4263094B2 (ja) 2009-05-13
IS2419B (is) 2008-10-15
HRP20040194A2 (en) 2004-08-31
ZA200401459B (en) 2004-11-22
BR0212173A (pt) 2004-07-20
HUP0401443A2 (hu) 2004-11-29
NZ531375A (en) 2005-06-24
KR100891630B1 (ko) 2009-04-03
WO2003020727A1 (en) 2003-03-13
CN1551883A (zh) 2004-12-01

Similar Documents

Publication Publication Date Title
DK1416935T3 (da) 4-Amino-6-phenyl-pyrrolo[2,3-d]pyrimidinderivater
EP1401840A4 (en) NEW 4-AMINO-5,6-SUBSTITUTED THIOPHENO 2,3 D | PYRIMIDINE
NO20042676L (no) 3-beta-d-ribofuranolsyltiazolo[4,5-d]pyrimidinnukleosider og anvendelser derav
NO20021694D0 (no) Pyrazolo[4,3-d]pyrimidinderivater
TWI371450B (en) Novel substituted dihydro 3-halo-1h-pyrazole-5-carboxylates,their preparation and use
DK1427733T3 (da) Thieno[2,3-d]pyrimidiner med kombineret LH- og FSH-agonistisk virkning
NO20022738L (no) Pyrrolo(2,3-d)pyrimidinforbindelser
MXPA03004439A (es) Aminotiazoles y su uso como antagonistas del receptor de adenosina.
NO20030033L (no) Pyrido[2,3-D]pyrimidin- og pyrimido[4,5-D]pyrimidin- nukleosider
DK1210349T3 (da) Pyrazolo[4,3-d]pyrimidiner
NO20026247D0 (no) 5-aminoalkyl-pyrazolo[4,3-d]pyrimidiner med en fosfodiesterase V-inhiberende virkning
DK1427734T3 (da) Glycin-substituerede thieno[2,3-d]pydimidiner med kombineret LH- og FSH-agonistisk aktivitet
HUP0303005A3 (en) Pharmaceutical compositions comprising pyrazolo[4,3-d]pyrimidines or thienopyrimidines and endothelin receptor antagonists
PL363077A1 (en) Use of pyrazolo[4,3-d]pyrimidines
PL361890A1 (en) Use of pyrazolo[4,3-d]pyrimidines
DE50103649D1 (de) 2-aminoalkyl-thieno[2,3-d]pyrimidine
GB2363377B (en) Novel thieno[2,3-d]pyrimidinediones and therapeutic uses thereof
HK1064386A (en) Glycine-substituted thieno [2,3-d] pyrimidines with combined lh and fsh agonistic activity
HK1064387A (en) Thieno [2,3-d] pyrimidines with combined lh and fsh agonistic activity
PT1326866E (pt) 3,4-di-hidropirido[1,2-a]pirimidinas substituidas
JP2003192065A5 (no)
AU2002305292A1 (en) Novel 4-amino-5,6-substituted thiopheno(2,3-d)pyrimidines
AU2002226519A1 (en) Pyrrolo(2,3-d)pyrimidine and their use as purinergic receptor antagonists

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees